To explore the functional significance of cGMP-dependent protein kinase type I (cGKI) in the regulation of erythrocyte survival, gene-targeted mice lacking cGKI were compared with their control littermates. By the age of 10 weeks, cGKI-deficient mice exhibited pronounced anemia and splenomegaly. Compared with control mice, the cGKI mutants had significantly lower red blood cell count, packed cell volume, and hemoglobin concentration. Anemia was associated with a higher reticulocyte number and an increase of plasma erythropoietin concentration. The spleens of cGKI mutant mice were massively enlarged and contained a higher fraction of Ter119(+) erythroid cells, whereas the relative proportion of leukocyte subpopulations was not changed. The Ter119(+) cGKI-deficient splenocytes showed a marked increase in annexin V binding, pointing to phosphatidylserine (PS) exposure at the outer membrane leaflet, a hallmark of suicidal erythrocyte death or eryptosis. Compared with control erythrocytes, cGKI-deficient erythrocytes exhibited in vitro a higher cytosolic Ca(2+) concentration, a known trigger of eryptosis, and showed increased PS exposure, which was paralleled by a faster clearance in vivo. Together, these results identify a role of cGKI as mediator of erythrocyte survival and extend the emerging concept that cGMP/cGKI signaling has an antiapoptotic/prosurvival function in a number of cell types in vivo. 
Introduction
Nitric oxide (NO) has previously been shown to be a powerful regulator of cell survival [Dimmeler et al., 2002; Hoffmann et al., 2001; Liu and Stamler 1999; Traister et al., 2004] . Depending on the source or concentration of NO and on the influence of additional regulators, NO may stimulate or inhibit apoptosis [Brune 2003 ]. NO exerts its effects in part through S-nitrosylation of target proteins. However, the effect of NO donors on Ca 2+ -induced phosphatidylserine exposure, a hallmark of apoptosis, could be mimicked by cGMP analogues [Nagai-Kusuhara et al., 2007] , suggesting the involvement of soluble guanylyl cyclase, cGMP and the cGMP-dependent protein kinase type I (cGKI), a well-known signalling cascade downstream of NO [Fleming et al., 1999; Friebe and Koesling 2003; Schlossmann et al., 2003 ].
Erythroid cells possess a functional NO/cGMP pathway [Chen and Mehta 1998; Ikuta et al., 2001; Kleinbongard et al., 2006] , which thus may be involved in the regulation of eryptosis, the suicidal death of erythrocytes [Lang et al., 2005] . Eryptosis may follow activation of Ca
2+
-permeable cation channels [Lang et al., 2003a] and subsequent Ca 2+ entry leading to activation of Ca
-sensitive K + channels, exit of KCl with osmotically obliged water and thus cell shrinkage [Lang et al., 2003b] . In addition, the Ca 2+ entry triggers the Ca
-sensitive scrambling of the cell membrane [Bratosin et al., 2001; Woon et al., 1999] with subsequent exposure of phosphatidylserine at the erythrocyte surface [de Jong et al., 2002; Lang et al., 2003a; Matarrese et al., 2005] . Cell membrane scrambling may further be triggered by ceramide [Lang et al., 2004] and activation of protein kinase C [Klarl et al., 2006] . Phosphatidylserine-exposing erythrocytes bind to phosphatidylserine receptors [Fadok et al., 2000] and are thus recognised, engulfed, and degraded by macrophages [Boas et al., 1998 ]. Accordingly, similar to erythrocyte senescence [Barvitenko et al., 2005; Bosman et al., 2005; Schwarzer et al., 2005] and neocytolysis [Rice and Alfrey 2005] , eryptosis leads to clearance of affected erythrocytes from circulating blood.
The present study has been performed to explore the role of cGKI in the survival of circulating erythrocytes. To this end, experiments have been performed to compare gene targeted mice lacking functional cGKI with their control littermates.
Results
The arterial acid base status as well as the most important plasma electrolytes (Na, K, Ca) did not differ between both mouse lines (data not shown).
The analysis of peripheral blood showed significant erythrocyte abnormalities in conventional cGKI knockout (cGKI ko) mice as compared to litter-matched control (ctr) mice. The red blood cell (RBC) counts, hematocrit (HCT), and hemoglobin (HGB) concentration were significantly smaller in 10-week-old cGKI ko mice than in ctr mice (Fig. 1A) . The difference was larger for erythrocyte number (≈52%) than for packed cell volume (≈33%) and hemoglobin (≈31%). Accordingly, the mean corpuscular volume (MCV) and the mean corpuscular hemoglobin content (MCH) of an erythrocyte were higher in cGKI ko mice than in ctr mice, whereas the mean corpuscular hemoglobin concentration (MCHC) was not altered. Thus, lack of cGKI cGKI+&+eryptosis_RF+060907-3.doc 4 leads to marked anemia. In theory, the anemia could have resulted from decreased erythrocyte formation, which should be reflected by a decreased number of reticulocytes. However, the reticulocyte number was higher in cGKI ko than in ctr mice (Fig. 1B) . Consistent with reticulocytosis, the red blood cell distibution width (RDW) was increased in cGKI ko mice (Fig. 1A) . Thus, the anemia could not be explained by decreased formation of erythrocytes. The increased reticulocyte number in cGKI ko mice could have resulted from enhanced stimulation of erythropoiesis by erythropoietin. As illustrated in Fig. 1C , the plasma erythropoietin concentration was indeed about twofold higher in cGKI ko than in ctr mice. The increased reticulocyte and erythropoietin levels could be indicative of hemolytic anemia in cGKI ko mice. To explore this possibility, the plasma concentration of haptoglobin was determined. The haptoglobin concentration in anemic cGKI ko mice was similar in both genotypes (in mg/ml, cGKI ko 0.11 ± 0.02, n=8; ctr 0.12 ± 0.03, n=11) excluding a hemolytic nature of the observed anemia. Moreover, iron deficiency due to chronic bleeding or impaired iron absorption is unlikely to account for the anemia, since the plasma transferrin levels were again similar in both genotypes (in mg/ml, cGKI ko 1.17 ± 0.05, n=8; ctr 1.37 ± 0.08, n=7). Moreover, the erythrocytes of cGKI ko mice were not microcytic (Fig.1A ).
The anemia of cGKI-deficient mice was associated with severe splenomegaly. Based on the organ/body weight ratio, 10-week-old cGKI ko mice had ≈3-fold larger spleens than control mice, whereas the size of the heart and kidneys was normal ( Fig. 2A,B) . Analysis of individual animals revealed that the splenomegaly was evident in most cGKI ko mice aged 8 to 10 weeks (Fig. 2C) . It is important to note that conventional cGKI ko mice have a severe smooth muscle (SM) dysfunction, which causes premature death of ≈50% of the mutant animals by 6 weeks of age. To test whether the anemia and splenomegaly of cGKI ko mice was linked to their SM dysfunction and poor health status, another cGKI-deficient mouse model, the so-called cGKI SM rescue mouse [Weber et al., 2007] , was also analysed. In cGKI SM rescue mice, the expression of cGKI has been restored selectively in SM cells but not in other cell types resulting in the rescue of SM dysfunction and a dramatic extension of life span to more than one year [Weber et al., 2007] . Thus, cGKI SM rescue mice are a useful genetic model to study the role of cGKI in non-SM cells of relatively "healthy" mice.
Similar to "older" conventional cGKI ko mice, adult (8-to 40-week old) cGKI SM rescue mice were anemic (RBC in 10 6 /µl, ctr 9.9 ± 0.2, n=22; SM rescue 7.7 ± 0.3, n=17; P<0.001) and showed massive splenomegaly at all ages analysed (Fig. 2C) . The fact that the anemia and splenomegaly were also present in the relatively "healthy" cGKI SM rescue mouse model indicated that these defects were not secondary due to the poor health condition of conventional cGKI ko mice and that they are not the cause of their premature death.
Further experiments were performed to elucidate the characteristics of the cells that apparently accumulated in the enlarged spleens of the cGKI-deficient mice. Freshly prepared splenocytes were stained with an antibody against Ter119, a marker of late-stage murine erythroid cells and mature erythrocytes and with annexin V to examine the externalization of phosphatidylserine (PS) indicative of suicidal cell death.
Flow-cytometric analysis showed that cGKI mutant mice had, proportionally, ≈96% more Ter119 + splenocytes than ctr mice (Fig. 2D , (Table 1) .
Moreover, the analysis of splenocytes for intracellular and secreted cytokines did not reveal altered levels of pro-inflammatory (IL-2, IL-17, IFN-γ, TNF) or anti-inflammatory (IL-4, IL-10) mediators in the spleens of cGKI mutants compared to controls (data not shown). Thus, the increased spleen size of the cGKI-deficient mice was not due to an increase in nonerythroid cells including lymphocytes, but was caused, at least in large part, by a massively increased number of eryptotic erythrocytes.
The accumulation of erythrocytes in the spleens of cGKI-deficient animals could be linked to their higher sensitivity to eryptosis. Therefore, it was explored whether cGKI signaling plays a role in eryptosis.
Western blot analysis showed that cGKI protein is present in both, erythroid cells from the bone marrow as well as in peripheral erythrocytes (Fig. 3 ). To exclude a potential contamination of the erythroid cells with platelets containing a high level of cGKI Hofmann et al., 2006] , the same membranes were stained for the platelet marker, thrombospondin-1 (TSP-1). While TSP-1 was readily detected in platelet-rich plasma, it was not present in the erythroid cell preparations used for Western analysis, thus, excluding the contamination with platelets ( Fig. 3) . Following a 48 hours incubation in Ringer solution at 37°C, the percentage of PS-exposing erythrocytes was determined by flow cytometry. Erythrocytes from cGKI ko mice showed a significantly higher percentage of PS-exposing erythrocytes than ctr mice (Fig. 4A ).
Externalization of PS is stimulated by an increased cytosolic Ca 2+ concentration [Lang et al., 2003a] . Ca
2+
imaging with Fluo-3 showed that the cytosolic Ca 2+ concentration was indeed significantly higher in cGKI ko erythrocytes than in ctr cells (Fig. 4B ). These data suggested that cGKI inhibits erythrocyte death in vitro by reducing the cytosolic Ca 2+ concentration, which in turn limits the exposure of PS at the cell surface. To investigate whether cGKI deficiency also affected the mechanical properties of the erythrocytes, cGKI ko and ctr erythrocytes were exposed to shear stress and the resulting cell elongation as a measure of erythrocyte flexibility was determined using laser-defractometry. The cGKI ko erythrocytes were slightly but significantly more flexible than ctr cells. For instance, the % elongation at a shear stress of 3.1 Pa in a high viscosity solution (24.4 mPa*s) were 24 ± 0.4 in cGKI ko and 19 ± 0.3 in ctr erythrocytes (P<0.05), whereas the % elongation at a shear stress of 2.6 Pa in a low viscosity solution (10.4 mPa*s) were 17 ± 0.2 in cGKI ko and 14 ± 0.4 in ctr erythrocytes (P<0.05). Since the deformability of cGKI-deficient erythrocytes was not impaired and in fact slightly improved, their mechanical properties could not account for their accumulation in the spleens of cGKI mutant mice.
The previous experiments suggested that cGKI deficiency promotes the death of erythrocytes, which might accumulate in the spleens of the mutant animals, thus leading to splenomegaly. To determine their in vivo survival, erythrocytes were isolated from control or cGKI ko donor mice, labeled with carboxyfluorescein diacetate succinimidyl ester (CFSE), and subsequently injected into the tail vein of ctr or SM rescue recipient mice. The clearance of CFSE-labeled erythrocytes from the circulation, an indirect indicator of erythrocyte death, was monitored over 24 days (Fig. 5 ). In line with their higher susceptibility to eryptosis in vitro, the cGKI ko erythrocytes disappeared more rapidly in ctr mice than ctr erythrocytes in ctr mice in vivo. As expected, ctr erythrocytes injected into cGKI mutant mice with splenomegaly were cleared very rapidly, most likely due to their retention in the enlarged spleens of the recipient mice (Fig. 5) . Together, these data suggested that the anemia of cGKI-deficient mice is not only due to an erythrocyte-autonomous component, i.e. increased eryptosis, but is potentiated by the development of an enlarged spleen retaining more erythrocytes than a normal spleen. Along those lines, anemia but not splenomegaly was detectable in 3-to 4-week-old cGKI ko mice (Fig. 6) , whereas 10-week-old knockout mice were both anemic and had enlarged spleens (Figs. 1A and 2A-C). Thus, it appears that the anemia due to eryptosis precedes the splenomegaly in cGKI-deficient mice.
Discussion
The present study shows that cGKI-deficient mice develop anemia and splenomegaly. The anemia is most likely not due to impaired formation but rather due to decreased survival of erythrocytes. The increased levels of plasma erythropoietin and reticulocytes indicate that erythropoiesis is indeed activated in cGKI-deficient mice, but eventually cannot compensate for the loss of erythrocytes resulting in anemia.
Ter119 + erythroid cells with an increased level of PS-exposure accumulate in the spleens of the mutant animals explaining the enlarged spleens and supporting a role of cGKI signaling in erythrocyte survival. Indeed, cGKIdeficient erythrocytes show a decreased survival both in vitro and in vivo. Mechanistically, the decreased survival of cGKI-deficient erythrocytes might result from an increased intracellular Ca 2+ concentration, which triggers the exposure of PS at the erythrocyte surface followed by engulfment by splenic macrophages.
The cytosolic Ca 2+ concentration is higher in circulating erythrocytes from cGKI-deficient mice as compared to ctr mice. It is well known that the NO/cGMP/cGKI pathway inhibits agonist-induced increases in cytosolic Ca 2+ in vascular smooth muscle cells Pfeifer et al., 1998 ]. Many studies have suggested that this pathway decreases the cytosolic Ca 2+ concentration also in a variety of other cell types and that the Ca 2+ lowering effect might, at least in part, be due to inhibition of Ca 2+ entry through Ca 2+ -permeable channels [Abdallah et al., 2005; Ay et al., 2006; Dervaux et al., 2006; Gomes et al., 2006; Huang et al., 2006; Kwan et al., 2006; Ma and Wang 2006] . Moreover, cGMP stimulates the Ca 2+ ATPase [Dedkova and Blatter 2002; Ogurusu et al., 1990; Rashatwar et al., 1987; Uneyama et al., 1998; Vrolix et al., 1988] , participating in the regulation of erythrocyte Ca 2+ concentration [Davis et al., 1982; Xu and Roufogalis 1988] . In line with their increased cytosolic Ca 2+ concentration, which is a well-known trigger of phospholipid scrambling [Lang et al., 2003a] , cGKI-deficient erythrocytes show increased surface exposure of PS, a hallmark of eryptosis [Bratosin et al., 2001; Woon et al., 1999] . The exposure of PS at the erythrocyte surface mediates the binding to PS receptors of macrophages [Fadok et al., 2000] followed by engulfment [Boas et al., 1998 ] and clearance from circulating blood . Indeed, cGKIdeficient erythrocytes are more rapidly cleared from the circulation, thus leading to the development of anemia.
The mechanical properties of cGKI-deficient erythrocytes were not affected adversely and, therefore, could not contribute to their accumulation in the spleen. Secondly, the anemia and splenomegaly is similarly present in "sick" conventional cGKI knockout mice and in relatively "healthy" cGKI smooth muscle rescue mice. Third, the anemia appears to precede the splenomegaly excluding the possibility that the development of a large spleen and the associated increased clearance of erythrocytes is the primary cause of the anemia. Thus, we propose that the primary defect leading to anemia in cGKI-deficient mice is a higher susceptibility of mature erythrocytes to eryptosis, which results in accumulation of the apoptotic cells in the spleen and, thereby, in its enlargement and further retention of erythrocytes. In this way, a vicious cycle is generated in which anemia and splenomegaly potentiate each other to reach the level observed in the adult cGKI mouse mutants.
In conclusion, the present study demonstrates that lack of functional cGKI in erythrocytes leads to an increased cytosolic Ca 2+ concentration with subsequent breakdown of PS asymmetry, accelerated clearance of circulating erythrocytes, and anemia despite counterregulation by erythropoietin release. These observations identify a novel function of cGKI signaling in the regulation of erythrocyte survival and support the emerging concept that pathways via NO, cGMP, and cGKI stimulate cell growth and survival in a number of cell types in vivo [Feil et al., 2005a; Fiedler et al., 2006; Wolfsgruber et al., 2003; Yamahara et al., 2003] .. The positive effect of cGKI on erythrocyte survival also suggests novel therapeutic options to treat anemia with cGMPelevating drugs.
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Materials and Methods

Experimental animals and cells
Experiments were performed with 3-to 10-week-old conventional cGKI knockout mice [Wegener et al., 2002] carrying the L-null allele (cGKI ko mice, genotype: cGKI L-/L-) and with 8-to 45-week-old cGKI smooth muscle rescue mice [Weber et al., 2007] Blood was retrieved either by puncture of the retroorbital venous plexus or, in case of sacrificed mice, by puncture of the heart, and collected in heparin-or EDTA-coated tubes. Bone marrow was obtained by rinsing femur and tibia with PBS. Cells from the bone marrow and spleen were separated with Netwells (Corning) prior to further analysis.
Blood and plasma parameters
Erythrocyte number, packed cell volume, mean corpuscular volume and blood hemoglobin concentration were determined using an electronic hematology particle counter (type MDM 905 from Medical Diagnostics Marx; Butzbach, Germany) equipped with a photometric unit for hemoglobin determination. The gating has been adjusted for the application on mouse erythrocytes. These measurements were confirmed by the measurement of hematocrit by centrifugation at 15000g for 3 minutes, measuring the hemoglobin concentration photometrically at 546nm after adding of 20 µl blood to 3 ml of a hemoglobin transformation solution (Dr. Lange AG, Hegnau, Switzerland) and by counting the red cells manually after 1:400 dilution with Heyem's solution (Fluka, Buchs, Switzerland) in a Neubauer chamber. Using the hematocrit, hemoglobin and red cell count obtained this way, the MCV, MCH and MCHC were calculated.
The relative distribution width (RDW) was determined from images of blood smears taken with a CCD camera (Axiocam, Zeiss, Deisenhofen, Germany) at a magnification of 400x (Axioskop, Zeiss). Of cGKI+&+eryptosis_RF+060907-3.doc 9 1829 to 3444 individual erythrocytes of each animal (n=3 to 4) the size was determined using an image analyzing system (MCID, Ontario, Canada). The obtained standard deviations and the means of the erythrocyte size were used to calculate the coefficient of variation as a measure for the RDW.
For determination of relative reticulocyte numbers, 5 µl of whole blood were added to 1 ml Retic- Arterial acid base status and the plasma concentration of sodium, potassium and calcium were determined with automatic blood gas analyzer (pHOx-plus, Nova Biomedical, Waltham, MA, USA).
The plasma concentration of erythropoietin, haptoglobin, and transferrin were determined using immunoassay kits according to the manufacturer's instructions (erythropoietin: R&D systems, WiesbadenNordenstadt, Germany; others: Kamiya Biomedical Company, Seatlle, USA).
Analysis of spleens
Single cell suspensions of freshly isolated spleens were stained for surface markers and intracellular cytokines and analyzed by flow cytometry according to standard procedures. Antibodies to Ter119, CD41, CD3, CD4, CD8, B220, IL-2, IL-4, IL-10, IL-17, IFN-γ, TNF, and appropriate isotype controls labeled with FITC or PE were obtained from BD, Germany. Annexin V-FITC staining was performed using an Apoptosis Detection Kit (BD, Germany). For intracellular cytokine staining, isolated splenocytes were stimulated with PMA (15 ng/ml) and ionomycin (1.5 µg/ml) (both Sigma, Germany) for 4 hours in the presence of Brefeldin A (Golgi Plug, BD, Germany). Cells were fixed in 2% formaldehyde, washed and permeabilized with 0.5% Saponin / 0.5% BSA and incubated with the indicated antibodies.
After washing, 50.000 or 100.000 events were counted on a FACS Calibur (BD, Germany) and data were analyzed using CellQuest software (BD, Germany). For investigating the proliferative capacity of splenocytes, 1x10 5 cells per well were cultured in medium or stimulated with LPS (1µg/ml). Cell proliferation was examined by measuring DNA synthesis using [ 3 H]thymidine incorporation (1.25 µCi/ml) for 12 hours before harvesting and counting using a MicroBeta device (Perkin Elmer, Germany).
Western blot analysis
Erythroid cells were isolated from bone marrow and peripheral blood by immunomagnetic selection using magnetically labelled Anti-Ter-119 MicroBeads and magnetic cell sorting (MACS, Miltenyi Biotec) cGKI+&+eryptosis_RF+060907-3.doc [Kina et al., 2000] . Proteins were separated on a SDS gel, transferred to a PVDF membrane and stained with a polyclonal rabbit antiserum to cGKI [Feil et al., 2005b] or with an antibody against thrombospondin-1 (TSP-1) (Lab Vision). As a positive control for both cGKI as well as TSP-1 expression, platelet-rich plasma was also loaded.
Analysis of phosphatidylserine exposure and intracellular Ca 2+ in peripheral erythrocytes
Erythrocytes were washed two times in Ringer solution (in mM: 125 NaCl, 5 KCl, 1 MgSO 4 , 32 N-2-hydroxyethylpiperazine-N-2-ethanesulfonic acid (HEPES), 5 glucose, 1 CaCl 2 , pH = 7.4). Then, erythrocytes at a final hemtocrit of 0.4% were incubated in Ringer solution at 37°C for 48 hours. After incubation, FACS analysis was performed essentially as described [Andree et al., 1990; Lang et al., 2003a] . 
Statistics
Data are expressed as mean ± SEM and statistical analysis was made by two-tailed unpaired t test or by two way ANOVA followed by Bonferroni post hoc test if appropriate. Significance was determined at P<0.05. donor erythrocytes injected into recipient mice were performed: ctr into ctr (open boxes, n=4), ko into ctr (black triangles, n=4), and ctr into SM rescue (black diamonds, n=3). The percentage of CFSE-labeled cells is plotted against time after injection (**, P<0.01, ko into ctr vs. ctr into ctr at indicated time points).
Figure legends
ANOVA showed a significant difference between experimental groups for both ko into ctr vs. ctr into ctr (P<0.001) as well as ctr into SM rescue vs. ctr into ctr (P<0.001). 
